Indications
| Mesh Heading | Maximum Phase | Reference | |
|---|---|---|---|
| Kidney Diseases; Kidney Failure, Chronic | Phase 1/Phase 2 | ClinicalTrials | |
| Lymphoproliferative Disorders | Phase 1 | ClinicalTrials | |
| Kidney Diseases | Phase 1 | ClinicalTrials | |
| Psoriasis | Phase 2 | ClinicalTrials | |
| Leukemia; Lymphoma | Phase 1 | ClinicalTrials | |
| Graft vs Host Disease | Phase 1 | ClinicalTrials | |
| Multiple Myeloma; Myelodysplastic Syndromes | Phase 2 | ClinicalTrials | |
| Psoriasis | Phase 2 | ClinicalTrials | |
| Graft vs Host Disease | Phase 1 | ClinicalTrials | |
| Graft vs Host Disease | Phase 1 | ClinicalTrials | |
| Kidney Failure, Chronic; Renal Insufficiency | Phase 2 | ClinicalTrials |
CONTENTS